Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia

Aldryhim, AY; Alomair, A; Alqhtani, M; Mahmoud, MA; Alshammari, TM; Pont, LG; Kamal, KM; Aljadhey, H; Mekonnen, AB; Alwhaibi, M; Balkhi, B; Alhawassi, TM

Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia

Aldryhim, AY Alomair, A Alqhtani, M Mahmoud, MA Alshammari, TM Pont, LG

Kamal, KM Aljadhey, H Mekonnen, AB Alwhaibi, M Balkhi, B Alhawassi, TM

Permalink

Publication Type:: Journal Article
Citation:: Expert Opinion on Drug Safety, 2019, 18 (8), pp. 745 - 752
Issue Date:: 2019-08-03

Closed Access

	Filename	Description	Size
	Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.pdf	Published Version	1.1 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Aldryhim, AY	en_US
dc.contributor.author	Alomair, A	en_US
dc.contributor.author	Alqhtani, M	en_US
dc.contributor.author	Mahmoud, MA	en_US
dc.contributor.author	Alshammari, TM	en_US
dc.contributor.author	Pont, LG https://orcid.org/0000-0002-8545-716X	en_US
dc.contributor.author	Kamal, KM	en_US
dc.contributor.author	Aljadhey, H	en_US
dc.contributor.author	Mekonnen, AB	en_US
dc.contributor.author	Alwhaibi, M	en_US
dc.contributor.author	Balkhi, B	en_US
dc.contributor.author	Alhawassi, TM	en_US
dc.date.issued	2019-08-03	en_US
dc.identifier.citation	Expert Opinion on Drug Safety, 2019, 18 (8), pp. 745 - 752	en_US
dc.identifier.issn	1474-0338	en_US
dc.identifier.uri	http://hdl.handle.net/10453/136286
dc.description.abstract	© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Adverse drug reactions (ADRs) are a pervasive global problem, and its management is integral to patient safety and healthcare quality. Pharmacists play a pivotal role in monitoring and reporting ADRs, which has a direct impact on patient care. The aim of this study was to identify potential factors that facilitate pharmacists in community and hospital settings to report ADRs. Methods: A cross-sectional, online survey using a validated questionnaire was administered to pharmacists working in community and hospital pharmacies in Saudi Arabia. Results: 1,717 community and 153 hospital pharmacists participated in this study. Only 10.2% and 26.8% of community and hospital pharmacists, respectively, admitted ever reporting an ADR. The most reported factors that may facilitate ADRs reporting have included ongoing improvements in therapeutic knowledge about ADRs, attending educational programs with continuous medical education credits, the seriousness of the experienced ADRs and accessibility to patients’ medical profile. The impact of peers by seeing colleagues reporting ADRs and ADRs due to herbal or traditional medicine were the least important factors reported by pharmacists. Conclusion: The study identified factors that can effectively address the under-reporting of ADRs by pharmacists. A multi-stakeholder, multi-pronged approach of ADR reporting is needed to develop greater awareness of this issue among pharmacists.	en_US
dc.relation.ispartof	Expert Opinion on Drug Safety	en_US
dc.relation.isbasedon	10.1080/14740338.2019.1632287	en_US
dc.subject.classification	Pharmacology & Pharmacy	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Cross-Sectional Studies	en_US
dc.subject.mesh	Adverse Drug Reaction Reporting Systems	en_US
dc.subject.mesh	Health Knowledge, Attitudes, Practice	en_US
dc.subject.mesh	Professional Role	en_US
dc.subject.mesh	Adult	en_US
dc.subject.mesh	Pharmacists	en_US
dc.subject.mesh	Pharmacy Service, Hospital	en_US
dc.subject.mesh	Community Pharmacy Services	en_US
dc.subject.mesh	Saudi Arabia	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Male	en_US
dc.subject.mesh	Pharmacovigilance	en_US
dc.subject.mesh	Drug-Related Side Effects and Adverse Reactions	en_US
dc.subject.mesh	Surveys and Questionnaires	en_US
dc.title	Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia	en_US
dc.type	Journal Article
utslib.citation.volume	8	en_US
utslib.citation.volume	18	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
utslib.for	1007 Nanotechnology	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	8	en_US
pubs.publication-status	Published	en_US
pubs.volume	18	en_US

Abstract:

© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Adverse drug reactions (ADRs) are a pervasive global problem, and its management is integral to patient safety and healthcare quality. Pharmacists play a pivotal role in monitoring and reporting ADRs, which has a direct impact on patient care. The aim of this study was to identify potential factors that facilitate pharmacists in community and hospital settings to report ADRs. Methods: A cross-sectional, online survey using a validated questionnaire was administered to pharmacists working in community and hospital pharmacies in Saudi Arabia. Results: 1,717 community and 153 hospital pharmacists participated in this study. Only 10.2% and 26.8% of community and hospital pharmacists, respectively, admitted ever reporting an ADR. The most reported factors that may facilitate ADRs reporting have included ongoing improvements in therapeutic knowledge about ADRs, attending educational programs with continuous medical education credits, the seriousness of the experienced ADRs and accessibility to patients’ medical profile. The impact of peers by seeing colleagues reporting ADRs and ADRs due to herbal or traditional medicine were the least important factors reported by pharmacists. Conclusion: The study identified factors that can effectively address the under-reporting of ADRs by pharmacists. A multi-stakeholder, multi-pronged approach of ADR reporting is needed to develop greater awareness of this issue among pharmacists.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/136286